A cardiac-specific reporter genetically engineered into human embryonic stem cells allows the optimization of differentiation protocols and the identification of cell-surface markers—a welcome new tool to help isolate and define cardiac cell lineages.
References
Elliott, D.A. et al. Nat. Methods 8, 1037–1040 (2011).
Dubois, N.C. et al. Nat. Biotechnol. published online, 10.1038/nbt.2005 (23 October 2011).
Wu, S.M. et al. Cell 127, 1137–1150 (2006).
Christoforou, N. et al. J. Clin. Invest. 118, 894–903 (2008).
Masino, A.M. et al. Circ. Res. 95, 389–397 (2004).
Bu, L. et al. Nature 460, 113–117 (2009).
Kita-Matsuo, H. et al. PLoS ONE 4, e5046 (2009).
He, J.Q., Ma, Y., Lee, Y., Thomson, J.A. & Kamp, T.J. Circ. Res. 93, 32–39 (2003).
Carvajal-Vergara, X. et al. Nature 465, 808–812 (2010).
Moretti, A. et al. N. Engl. J. Med. 363, 1397–1409 (2010).
Ieda, M. et al. Cell 142, 375–386 (2010).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
T.J.K. is a co-founder and consultant for Cellular Dynamics International, a company that uses human pluripotent stem cells and their derivatives for research, drug discovery and drug testing.
Rights and permissions
About this article
Cite this article
Kamp, T. Recognizing heart cells in a crowd. Nat Methods 8, 1013–1016 (2011). https://doi.org/10.1038/nmeth.1780
Published:
Issue Date:
DOI: https://doi.org/10.1038/nmeth.1780
- Springer Nature America, Inc.
This article is cited by
-
Therapeutic potential of menstrual blood-derived endometrial stem cells in cardiac diseases
Cellular and Molecular Life Sciences (2019)
-
Challenges in identifying the best source of stem cells for cardiac regeneration therapy
Stem Cell Research & Therapy (2015)